Wealth Preservation Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Wealth Preservation Advisors's PFE Position: Q1 2026 in Review
Wealth Preservation Advisors increased its Pfizer (PFE) stake by 97% in Q1 2026, buying an estimated $8.04K and bringing the position to 614 shares worth $17.2K. The position accounts for 0.01% of the portfolio, ranked #334.
Wealth Preservation Advisors first reported a position in PFE in Q1 2025 and has held it in 5 quarters since. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Wealth Preservation Advisors held 614 shares of Pfizer worth $17.2K as of Q1 2026.
- Wealth Preservation Advisors bought 302 Pfizer shares in Q1 2026, an estimated $8.04K.
- Pfizer made up 0.01% of Wealth Preservation Advisors's portfolio in Q1 2026, its #334 holding.
- Wealth Preservation Advisors first reported a position in Pfizer in Q1 2025 and has held it in 5 quarters since.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Wealth Preservation Advisors's 13F filing for Q1 2026, filed 15 May 2026.